0001209191-15-081520.txt : 20151120
0001209191-15-081520.hdr.sgml : 20151120
20151120160924
ACCESSION NUMBER: 0001209191-15-081520
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20151118
FILED AS OF DATE: 20151120
DATE AS OF CHANGE: 20151120
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MCGLYNN MARGARET G
CENTRAL INDEX KEY: 0001215126
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 151246801
MAIL ADDRESS:
STREET 1: C/O MERCK & CO INC
STREET 2: ONE MERCK DRIVE PO BOX 100
CITY: WHITEHOUSE STATION
STATE: NJ
ZIP: 08889-0100
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-11-18
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001215126
MCGLYNN MARGARET G
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
1
0
0
0
Common Stock
2015-11-18
4
M
0
12500
57.27
A
13588
D
Common Stock
2015-11-18
4
S
0
12500
130.15
D
1088
D
Stock Option (right to buy)
57.27
2015-11-18
4
M
0
12500
0.00
D
2021-05-11
Common Stock
12500
0
D
Transaction made pursuant to Ms. McGlynn's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $130.15 (range $130.00 to $130.55).
Ms. McGlynn undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Fully vested.
Omar White, Attorney-In-Fact
2015-11-20